Drug Type Antibody toxin conjugate |
Synonyms Anti-Mesothelin Immunotoxin, CAT 5001, SS 1P + [1] |
Target |
Mechanism MSLN modulators(Mesothelin modulators), Apoptosis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of Lung | Phase 2 | US | 11 May 2011 | |
Lung Cancer | Phase 2 | US | 11 May 2011 | |
Pancreatic Cancer | Phase 2 | US | 11 May 2011 | |
Mesothelioma | Phase 2 | - | - | |
Mesothelioma | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Unresectable Lung Non-Small Cell Carcinoma | Phase 1 | US | 29 Dec 2009 | |
Crohn Disease | Phase 1 | AU | 01 Sep 2006 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Jul 2003 |
Not Applicable | 11 | qqymsphmjk(adgmwapajg) = cjvclzbnqp lzxqutajuy (ycmezftmxo, +) View more | - | 29 Oct 2013 | |||
qqymsphmjk(adgmwapajg) = xkxmhcdcfz lzxqutajuy (ycmezftmxo, +) View more | |||||||
Not Applicable | - | qxgownqkto(pznzklqbuy) = anjjhsvwaw ctwuoftlxu (iolnenokzj ) | Positive | 20 May 2011 | |||
Phase 1 | - | SS1P | xhexwhefrl(dcqjcfjdxw) = jjzfioaega vdzzfjlnyh (pwqzjffwwr ) | - | 20 May 2010 | ||
Phase 1 | 34 | uuchfgupso(brojipgajv) = ejyrefefux hsgtyodats (cadykoipgz ) View more | - | 20 Jun 2007 |